{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-006236","form_type":"8-K","ticker":"IPSC","cik":"0001850119","company_name":"Century Therapeutics, Inc.","filed_at":"2026-01-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.531959+00:00","generated_at":"2026-05-16T08:30:28.063490+00:00","sec_items":["5.07","8.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Century Therapeutics regains Nasdaq bid price compliance; reverse split not needed","bullets":["Nasdaq notified Century on Jan 22, 2026 that it regained compliance with minimum $1.00 bid price rule.","Stockholders approved reverse stock split (1:5–1:30) at special meeting earlier that day.","Company will not implement the reverse split due to regained compliance.","No other business was conducted; adjournment proposal was unnecessary."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-006236","json":"https://secwatch.observer/filing/0001104659-26-006236.json","markdown":"https://secwatch.observer/filing/0001104659-26-006236.md","text":"https://secwatch.observer/filing/0001104659-26-006236.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1850119/000110465926006236/0001104659-26-006236-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1850119/000110465926006236/tm263921d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T08:30:28.063490+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}